IER2 and ovarian carcinoma: IER5 and its family members IER5L and IER2 have undergone genetic alteration in ovarian cancer, including amplification and high expression, as shown in Figure 1A. It is expected that expression of the IER5 family genes is elevated in many ovarian cancer samples.